InvestorsHub Logo
Followers 0
Posts 180
Boards Moderated 0
Alias Born 08/07/2016

Re: James salmon post# 28469

Wednesday, 08/02/2017 11:24:30 AM

Wednesday, August 02, 2017 11:24:30 AM

Post# of 108192
James, my understanding from the PR this morning was that there will be data presented only from the monotherapy (ADXS-PSA) ARM of the combo study and not from the combination ARM.

While the benefit to patients appears evident from the statement you cited, it appears to be from monotherapy. Do you have a sense of why the combo data is not yet being presented? If my memory serves me right, the patient enrollment for the PSA combo trial started in December 2015, although I am not sure when they started enrolling for the combo ARM.

I honestly am not sure if I am being impatient or if it generally does take pretty long for combo patient enrollment to initial data. Any thoughts from your side?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News